KR20230129506A - 인간 유두종 바이러스 유사 입자 백신의 안정한 제제 - Google Patents

인간 유두종 바이러스 유사 입자 백신의 안정한 제제 Download PDF

Info

Publication number
KR20230129506A
KR20230129506A KR1020237026965A KR20237026965A KR20230129506A KR 20230129506 A KR20230129506 A KR 20230129506A KR 1020237026965 A KR1020237026965 A KR 1020237026965A KR 20237026965 A KR20237026965 A KR 20237026965A KR 20230129506 A KR20230129506 A KR 20230129506A
Authority
KR
South Korea
Prior art keywords
leu
ser
thr
pro
val
Prior art date
Application number
KR1020237026965A
Other languages
English (en)
Korean (ko)
Inventor
얀 리우
핑 후
신롱 챵
Original Assignee
사이노셀테크 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사이노셀테크 엘티디. filed Critical 사이노셀테크 엘티디.
Publication of KR20230129506A publication Critical patent/KR20230129506A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020237026965A 2021-01-14 2022-01-13 인간 유두종 바이러스 유사 입자 백신의 안정한 제제 KR20230129506A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110049777.7 2021-01-14
CN202110049777 2021-01-14
PCT/CN2022/071782 WO2022152204A1 (zh) 2021-01-14 2022-01-13 一种人***瘤病毒病毒样颗粒疫苗的稳定制剂

Publications (1)

Publication Number Publication Date
KR20230129506A true KR20230129506A (ko) 2023-09-08

Family

ID=82446926

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237026965A KR20230129506A (ko) 2021-01-14 2022-01-13 인간 유두종 바이러스 유사 입자 백신의 안정한 제제

Country Status (9)

Country Link
US (1) US20240075124A1 (zh)
EP (1) EP4292607A1 (zh)
JP (1) JP2024503452A (zh)
KR (1) KR20230129506A (zh)
CN (1) CN117083078A (zh)
AU (1) AU2022207569A1 (zh)
CA (1) CA3204802A1 (zh)
MX (1) MX2023008306A (zh)
WO (1) WO2022152204A1 (zh)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
CN101245099A (zh) * 2007-02-14 2008-08-20 马润林 重组人***瘤病毒l1衣壳蛋白的氨基酸序列及其应用
CN102349996B (zh) * 2011-10-17 2014-06-25 沈阳三生制药有限责任公司 人***瘤病毒药物组合物及其应用
WO2021013076A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒45型l1蛋白
CN114127095B (zh) * 2019-07-19 2024-04-09 神州细胞工程有限公司 嵌合的人***瘤病毒11型l1蛋白
CN114174319B (zh) * 2019-07-19 2024-05-14 神州细胞工程有限公司 嵌合的人***瘤病毒52型l1蛋白
WO2021013063A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒16型l1蛋白
CA3147850A1 (en) * 2019-07-19 2021-01-28 Sinocelltech Ltd. Chimeric papillomavirus l1 protein
WO2021013077A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒58型l1蛋白
CN114127097A (zh) * 2019-07-19 2022-03-01 神州细胞工程有限公司 嵌合的人***瘤病毒56型l1蛋白
CN114127099B (zh) * 2019-07-19 2024-04-19 神州细胞工程有限公司 嵌合的人***瘤病毒6型l1蛋白
WO2021013072A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒39型l1蛋白
BR112022001070A2 (pt) * 2019-07-19 2022-04-19 Sinocelltech Ltd Composição de imunogenicidade polivalente para papilomavírus humano
WO2021013060A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒51型l1蛋白
WO2021013070A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒35型l1蛋白
WO2021013075A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人***瘤病毒18型l1蛋白
CN114127096B (zh) * 2019-07-19 2024-04-05 神州细胞工程有限公司 嵌合的人***瘤病毒31型l1蛋白

Also Published As

Publication number Publication date
CA3204802A1 (en) 2022-07-21
MX2023008306A (es) 2023-07-19
WO2022152204A1 (zh) 2022-07-21
EP4292607A1 (en) 2023-12-20
CN117083078A (zh) 2023-11-17
US20240075124A1 (en) 2024-03-07
AU2022207569A1 (en) 2023-08-10
JP2024503452A (ja) 2024-01-25

Similar Documents

Publication Publication Date Title
JPH08322580A (ja) 乳頭腫ウイルス型特異的抗体
KR102640490B1 (ko) 키메라 유두종바이러스 l1 단백질
EP2251693B1 (en) Method and kit for detection of anti-avibacterium paragallinarum antibody
US20160000897A1 (en) Recombinant antigens of porcine circovirus 2 (pcv-2) for vaccine formulations, diagnostic kit and use thereof
CN112125961B (zh) 牛病毒性腹泻-牛传染性鼻气管炎二联亚单位融合疫苗及其鉴定方法
CN112280792B (zh) 人***瘤病毒基因,及载体,菌株,表达方法
RU2494106C2 (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
CN113403329B (zh) 一种用于猫冠状病毒的rna疫苗及其构建方法
CN110642927A (zh) 一种蛋白在制备预防化脓隐秘杆菌感染的药物中的应用
WO2021042947A1 (zh) 微环dna疫苗设计及应用
KR20230129506A (ko) 인간 유두종 바이러스 유사 입자 백신의 안정한 제제
CN110257405A (zh) 牛支原体乙醇脱氢酶基因及其编码蛋白与应用
CN112730829B (zh) 一种快速检测牡蛎疱疹病毒OsHV-1的胶体金试纸条及其应用
EP2658865A2 (en) IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
AU2020317321B2 (en) Polyvalent immunogenicity composition for human papillomavirus
CN111253477B (zh) 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用
CN104845985B (zh) 重组人***瘤病毒蛋白表达
RU2806424C2 (ru) Поливалентная иммуногенная композиция против папилломавируса человека
RU2808002C2 (ru) Химерный белок l1 папилломавируса
CN116462743B (zh) 鲍曼不动杆菌翻译延伸因子重组蛋白、制备方法及应用
TW202214671A (zh) 人乳頭瘤病毒多價免疫原性組合物
CN109750050B (zh) 重组人***瘤病毒45亚型蛋白表达
CN106893730B (zh) 重组人***瘤蛋白表达
Tailakova et al. CONSTRUCTION, EXPRESSION AND PURIFICATION OF BRUCELLA SPP. RECOMBINANT PROTEINS L7/L12 AND SODC IN E. COLI
CN117186191A (zh) 一种重组兔出血症病毒vp60蛋白、疫苗及其应用

Legal Events

Date Code Title Description
A201 Request for examination